The Medicines (Products for Human Use) (Fees) Regulations 2013 (revoked)
These Regulations revoke and re-enact in consolidated form, with some amendments, the Medicines (Products for Human Use) (Fees) Regulations 2012 (“the 2012 Regulations”) and the Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2012. They make amendments to the Medicines for Human Use (Clinical Trials) Regulations 2004 (“the Clinical Trials Regulations”).
Sign in to trackLast fetched 30 Apr 2026 · legislation.gov.uk
Lifecycle
Department
Made
07 Mar 2013
—
Comes into force
TBC
Enabling power
In accordance with section 129(6) of the Medicines Act 1968, the Secretary of State for Health and the Minister for Health, Social Services and Public Safety have consulted with such organisations as appear to them to be representative of interests likely to be substantially affected by these Regulations.
DocumentsOpen on legislation.gov.uk →